D. E. Shaw & Co. Inc. lessened its position in shares of Canopy Growth Co. (NASDAQ:CGC) by 7.8% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,355,925 shares of the company’s stock after selling 115,093 shares during the period. D. E. Shaw & Co. Inc.’s holdings in Canopy Growth were worth $43,430,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently made changes to their positions in CGC. Amundi Pioneer Asset Management Inc. raised its stake in Canopy Growth by 6.7% during the first quarter. Amundi Pioneer Asset Management Inc. now owns 36,373 shares of the company’s stock worth $1,577,000 after buying an additional 2,296 shares during the last quarter. Wells Fargo & Company MN raised its stake in Canopy Growth by 37.2% during the fourth quarter. Wells Fargo & Company MN now owns 26,960 shares of the company’s stock worth $664,000 after buying an additional 7,312 shares during the last quarter. Renaissance Technologies LLC bought a new position in Canopy Growth during the fourth quarter worth $5,308,000. Northern Trust Corp bought a new position in Canopy Growth during the fourth quarter worth $751,000. Finally, Raymond James Financial Services Advisors Inc. increased its stake in Canopy Growth by 49.3% in the fourth quarter. Raymond James Financial Services Advisors Inc. now owns 123,276 shares of the company’s stock valued at $3,031,000 after purchasing an additional 40,710 shares in the last quarter. 12.69% of the stock is owned by institutional investors and hedge funds.
Canopy Growth stock opened at $20.24 on Thursday. Canopy Growth Co. has a fifty-two week low of $13.83 and a fifty-two week high of $56.50. The stock has a market capitalization of $7.96 billion, a PE ratio of -5.66 and a beta of 2.10. The stock’s 50-day moving average price is $23.48. The company has a current ratio of 9.98, a quick ratio of 8.69 and a debt-to-equity ratio of 0.45.
Several research firms have weighed in on CGC. Zacks Investment Research downgraded shares of Canopy Growth from a “hold” rating to a “sell” rating in a research note on Wednesday, July 7th. CIBC decreased their price target on shares of Canopy Growth from C$38.00 to C$36.00 and set a “neutral” rating for the company in a research note on Wednesday, June 2nd. Canaccord Genuity raised shares of Canopy Growth from a “sell” rating to a “hold” rating in a research note on Tuesday, June 1st. Alliance Global Partners reaffirmed a “neutral” rating and issued a $32.00 price target (down from $40.00) on shares of Canopy Growth in a research note on Tuesday, June 1st. Finally, Desjardins decreased their price target on shares of Canopy Growth from C$55.00 to C$35.00 and set a “hold” rating for the company in a research note on Thursday, June 3rd. Three analysts have rated the stock with a sell rating, ten have issued a hold rating, three have issued a buy rating and one has issued a strong buy rating to the stock. The stock has an average rating of “Hold” and an average price target of $31.11.
About Canopy Growth
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products.
Recommended Story: What is FinTech?
Want to see what other hedge funds are holding CGC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Canopy Growth Co. (NASDAQ:CGC).
Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.